LFR
SGMO

Lehman Financial Resources’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Lehman Financial Resources’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-200
Closed -$1K – 289
2015
Q3 		$1K Hold
200
– – ﹤0.01% 429
2015
Q2 		$2K Hold
200
– – ﹤0.01% 388
2015
Q1 		$3K Hold
200
– – ﹤0.01% 377
2014
Q4 		$3K Hold
200
– – ﹤0.01% 364
2014
Q3 		$2K Hold
200
– – ﹤0.01% 387
2014
Q2 		$3K Hold
200
– – ﹤0.01% 362
2014
Q1 		$4K Hold
200
– – ﹤0.01% 349
2013
Q4 		$3K Hold
200
– – ﹤0.01% 350
2013
Q3 		$2K Hold
200
– – ﹤0.01% 356
2013
Q2 		$2K Buy
+200
New +$1.75K ﹤0.01% 322

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lehman Financial Resources's SGMO Position: Q4 2015 in Review

Lehman Financial Resources sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2015, closing a stake of 200 shares — an estimated $1K sold.

Lehman Financial Resources first reported a position in SGMO in Q2 2013 and held it in 10 quarters. The position peaked at $4K in Q1 2014. 141 funds tracked by Wall St. Rank hold SGMO as of Q4 2015.

  • Lehman Financial Resources reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
  • Lehman Financial Resources sold 200 SANGAMO THERAPEUTICS INC shares in Q4 2015, an estimated $1K.
  • Lehman Financial Resources first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 10 quarters.
  • Lehman Financial Resources's SANGAMO THERAPEUTICS INC position peaked at $4K in Q1 2014.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.